Viewing Study NCT00658567


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-01-10 @ 10:23 AM
Study NCT ID: NCT00658567
Status: COMPLETED
Last Update Posted: 2017-05-19
First Post: 2008-04-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis
Sponsor: ACADIA Pharmaceuticals Inc.
Organization: